JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

Search

Smith & Nephew PLC ADR

Cerrado

32.11 1.71

Resumen

Variación precio

24h

Actual

Mínimo

31.57

Máximo

32.26

Métricas clave

By Trading Economics

Ingresos

35M

331M

Ventas

203M

3.2B

P/B

Media del Sector

23.923

60.328

Rentabilidad por dividendo

2.29

Margen de beneficios

10.368

Empleados

16,988

EBITDA

133M

856M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+1.36% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

2.29%

2.24%

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-578M

15B

Apertura anterior

30.4

Cierre anterior

32.11

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Smith & Nephew PLC ADR Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

27 abr 2026, 23:15 UTC

Noticias de Eventos Importantes

U.K. Consumers Pay Less But Full Impact of Mideast War to Be Seen

27 abr 2026, 23:08 UTC

Ganancias
Principales Movimientos del Mercado

LendingClub Shares Gain on 1Q Profit, Revenue Beat

27 abr 2026, 23:58 UTC

Ganancias

Samsung SDI 1Q Net Profit Beat FactSet-Compiled Consensus

27 abr 2026, 23:58 UTC

Ganancias

Samsung SDI 1Q Net KRW56.10B Vs. Loss KRW216.00B >006400.SE

27 abr 2026, 23:56 UTC

Ganancias

Samsung SDI 1Q Oper Loss KRW155.60B Vs. Loss KRW434.10B >006400.SE

27 abr 2026, 23:56 UTC

Ganancias

Samsung SDI 1Q Rev KRW3.576T Vs. KRW3.177T >006400.SE

27 abr 2026, 23:48 UTC

Charlas de Mercado

Nikkei May Remain Rangebound Amid Uncertainty Over Iran Conflict -- Market Talk

27 abr 2026, 23:42 UTC

Charlas de Mercado

Australian Consumer Confidence Making a Slow Come Back -- Market Talk

27 abr 2026, 23:34 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Gold Edges Higher as Investors Assess Iran's Proposal to U.S. -- Market Talk

27 abr 2026, 23:30 UTC

Charlas de Mercado

Australia's NDIS Could Lose 'Social Licence' If Not Reined In -- Market Talk

27 abr 2026, 23:08 UTC

Charlas de Mercado

Polymetals's Revenue Outlook 'Extraordinary' for a Small-Cap Stock -- Market Talk

27 abr 2026, 23:02 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

27 abr 2026, 23:02 UTC

Charlas de Mercado

Warsh Will Probably Lean a Bit More Dovish Than Powell -- Market Talk

27 abr 2026, 22:42 UTC

Charlas de Mercado

BOJ Expected to Keep Rates On Hold; Guidance to Skew Hawkish -- Market Talk

27 abr 2026, 22:10 UTC

Ganancias

Haier Smart Home: Results Also Weighed by Weak Demand in China-U.S. Markets >600690.SH

27 abr 2026, 22:09 UTC

Ganancias

Haier Smart Home: Increase in Tariff Costs, Extreme Weather Conditions Hurt Results >600690.SH

27 abr 2026, 22:09 UTC

Ganancias

Haier Smart Home 1Q Net CNY4.65B Vs. Net CNY5.49B >600690.SH

27 abr 2026, 22:09 UTC

Ganancias

Haier Smart Home 1Q Rev CNY73.69B Vs. CNY79.12B >600690.SH

27 abr 2026, 21:56 UTC

Ganancias

Tsingtao Brewery: Cost Controls Among Factors Supporting Results >0168.HK

27 abr 2026, 21:55 UTC

Ganancias

Tsingtao Brewery 1Q Net CNY1.80B Vs. Net CNY1.71B >0168.HK

27 abr 2026, 21:55 UTC

Ganancias

Tsingtao Brewery 1Q Rev CNY10.29B Vs. CNY10.45B >0168.HK

27 abr 2026, 21:44 UTC

Ganancias

Tianqi Lithium: Higher Demand for Products From EV Sector Also Boosted Financial Performance >002466.SZ

27 abr 2026, 21:43 UTC

Ganancias

Tianqi Lithium: Increase in Average Selling Prices of Major Lithium Products Supported Results >002466.SZ

27 abr 2026, 21:41 UTC

Ganancias

Tianqi Lithium 1Q Rev CNY5.13B Vs. CNY2.58B >002466.SZ

27 abr 2026, 21:41 UTC

Ganancias

Tianqi Lithium 1Q Net CNY1.88B Vs. Net CNY104.27M >002466.SZ

27 abr 2026, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

27 abr 2026, 20:50 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Basic Materials Roundup: Market Talk

27 abr 2026, 20:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Financial Services Roundup: Market Talk

27 abr 2026, 20:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

27 abr 2026, 20:39 UTC

Ganancias

Nucor: Operating Segments Earnings Growth Driven by Trade Policies That Continue to Reduce Flood of Unfairly Traded Imports Into U.S. >NUE

Comparación entre iguales

Cambio de precio

Smith & Nephew PLC ADR previsión

Precio Objetivo

By TipRanks

1.36% repunte

Estimación a 12 Meses

Media 32 USD  1.36%

Máximo 32 USD

Mínimo 32 USD

De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Smith & Nephew PLC ADR Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

1 ratings

0

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

26.64 / 28.37Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Bullish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat